Results 131 to 140 of about 45,130 (266)
Background Inflammatory bowel disease (IBD), encompassing Crohn′s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition affecting the gastrointestinal tract. While significant progress has been made in managing IBD, the long‐term outcomes remain heterogeneous, prompting this cohort study.
Poria Hoseinialiabadi +7 more
wiley +1 more source
Background and Aims: Gallbladder cancer (GBC) is a rare type of cancer with a high rate of cancer-related mortality because it is usually diagnosed at an advanced stage; however, it may also be incidentally detected postcholecystectomy for cholelithiasis.
Christina Liava +3 more
doaj +1 more source
Objective To preliminarily explore the feasibility and clinical implications of using gadoxetic acid disodium (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (MRI) for assessing the gallbladder ejection fraction (GBEF) in patients with cholecystolithiasis.
Ruikun Zhang +14 more
wiley +1 more source
Adrenal myelolipoma associated with cholelithiasis
SushilK Gupta +7 more
openalex +1 more source
ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome [PDF]
Moustafa Biyoukar +11 more
openalex +1 more source
Rarity of Acute Pancreatitis as an Initial Presentation of Lung Carcinoma
Gallstones and alcohol consumption are the most common causes of acute pancreatitis. Lung carcinoma typically presents with respiratory symptoms, and in some cases, locoregional or distant metastases. However, acute pancreatitis as the initial manifestation of lung carcinoma is rare.
Navin Kumar +7 more
wiley +1 more source
The causal relationships between plasma metabolites and cholelithiasis/cholecystitis risks remain elusive. Using two-sample Mendelian randomization, we found that genetic proxied plasma campesterol level showed negative correlation with the risk of both ...
Jiarui Mi +9 more
doaj +1 more source
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. [PDF]
Pexidartinib (PLX3397) is a small molecule tyrosine kinase and colony-stimulating factor-1 inhibitor with FDA breakthrough therapy designation for tenosynovial giant-cell tumor, and currently under study in several other tumor types, including breast ...
Chien, A Jo +5 more
core
Aim. The retrospective analysis of prevalence, peculiarities of duration of biliary calculosis without gall bladder cholesterosis, biliary calculosis with gall-bladder cholesterosis and xanthogranulematous cholecystitis among persons who underwent ...
M B Shcherbinina, E V Zakrevskaia
doaj

